Literature DB >> 25061734

Effects of VEGF suppression by small hairpin RNA interference combined with radiotherapy on the growth of cervical cancer.

L Qi1, L N Xing2, X Wei3, S G Song1.   

Abstract

This study aimed to investigate the inhibition of vascular endothelial growth factor (VEGF) by small hairpin RNA (shRNA) interference combined with radiotherapy on the growth of cervical cancer SiHa cell xenografts in nude mice. The effective pVEGF-shRNA plasmid was screened by reverse transcription-polymerase chain reaction (RT-PCR), and the cell apoptosis rate was estimated by flow cytometry. A nude mouse cervical xenograft model was established and all models were divided into four groups: blank control, VEGF shRNA, radiotherapy, and combined treatment. We calculated the tumor growth curve and the inhibitory rate. The histopathological changes of the microvascular density and VEGF protein expression were observed by immunohistochemistry. The expressions of VEGF and hypoxia inducible factor-1α (HIF-1α) proteins in the tumor tissue were analyzed via Western blot. VEGF shRNA interference inhibited the expression of radiation-induced VEGF (P < 0.05), induced apoptosis (P < 0.05), downregulated the HIF-1α protein, and reduced angiogenesis. Compared with the other three groups, the combined treatment group showed the most significant effects (P < 0.01). VEGF shRNA interference combined with radiotherapy promotes the radiosensitivity of tumors via improvement of the hypoxic microenvironment.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25061734     DOI: 10.4238/2014.July.7.2

Source DB:  PubMed          Journal:  Genet Mol Res        ISSN: 1676-5680


  10 in total

1.  Upregulation of microRNA-129-5p inhibits cell invasion, migration and tumor angiogenesis by inhibiting ZIC2 via downregulation of the Hedgehog signaling pathway in cervical cancer.

Authors:  Ying-Fang Wang; Hong-Yun Yang; Xiao-Qin Shi; Yue Wang
Journal:  Cancer Biol Ther       Date:  2018-09-27       Impact factor: 4.742

2.  Repurposing propranolol as an antitumor agent in von Hippel-Lindau disease.

Authors:  Matthew J Shepard; Alejandro Bugarini; Nancy A Edwards; Jie Lu; Qi Zhang; Tianxia Wu; Zhengping Zhuang; Prashant Chittiboina
Journal:  J Neurosurg       Date:  2018-10-01       Impact factor: 5.115

Review 3.  Gene Therapy for Malignant and Benign Gynaecological Disorders: A Systematic Review of an Emerging Success Story.

Authors:  Ekati Drakopoulou; Nicholas P Anagnou; Kalliopi I Pappa
Journal:  Cancers (Basel)       Date:  2022-06-30       Impact factor: 6.575

Review 4.  Clinical Trials of Antiangiogenesis Therapy in Recurrent/Persistent and Metastatic Cervical Cancer.

Authors:  Jill K Alldredge; Krishnansu S Tewari
Journal:  Oncologist       Date:  2016-03-29

5.  VEGF silencing inhibits human osteosarcoma angiogenesis and promotes cell apoptosis via PI3K/AKT signaling pathway.

Authors:  Jian Zhao; Zi-Ru Zhang; Na Zhao; Bao-An Ma; Qing-Yu Fan
Journal:  Int J Clin Exp Med       Date:  2015-08-15

6.  Modulatory Effects of Chemoradiation on Angiogenic Factors and Laminin in Cervical Cancer: Link with Treatment Response

Authors:  Manoj Sharma; Rehan Khan; Mayank Aggarwal; Alpana Sharma
Journal:  Asian Pac J Cancer Prev       Date:  2017-11-26

7.  CD73 promotes proliferation and migration of human cervical cancer cells independent of its enzyme activity.

Authors:  Zhao-Wei Gao; Hui-Ping Wang; Fang Lin; Xi Wang; Min Long; Hui-Zhong Zhang; Ke Dong
Journal:  BMC Cancer       Date:  2017-02-15       Impact factor: 4.430

Review 8.  Targeted Gene Delivery Therapies for Cervical Cancer.

Authors:  Ángela Áyen; Yaiza Jiménez Martínez; Houria Boulaiz
Journal:  Cancers (Basel)       Date:  2020-05-21       Impact factor: 6.639

9.  Downregulation of VEGFA inhibits proliferation, promotes apoptosis, and suppresses migration and invasion of renal clear cell carcinoma.

Authors:  Fan-Chang Zeng; Ming-Qiang Zeng; Liang Huang; Yong-Lin Li; Ben-Min Gao; Jun-Jie Chen; Rui-Zhi Xue; Zheng-Yan Tang
Journal:  Onco Targets Ther       Date:  2016-04-12       Impact factor: 4.147

10.  Melatonin downregulates nuclear receptor RZR/RORγ expression causing growth-inhibitory and anti-angiogenesis activity in human gastric cancer cells in vitro and in vivo.

Authors:  Ri-Xiong Wang; Hui Liu; Li Xu; Hui Zhang; Rui-Xiang Zhou
Journal:  Oncol Lett       Date:  2016-06-15       Impact factor: 2.967

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.